F-14/15, Orbit Mall, Civil Lines, Jaipur-302006
support@thetaxheaven.com
F-14/15, Orbit Mall, Civil Lines, Jaipur-302006 support@thetaxheaven.comAdvanced Enzyme Technologies Ltd is one of India’s leading enzyme manufacturing companies, catering to pharmaceuticals, nutrition, food, and industrial applications across global markets. Known for its research-driven approach and sustainable business model, the company has steadily gained investors’ attention on NSE and BSE.
In this article, we’ll explore Advanced Enzyme Technologies’ share price targets from 2025 to 2030, along with its financial details, shareholding pattern, and long-term investment potential.
| Detail | Value |
|---|---|
| Open | ₹319.35 |
| Previous Close | ₹324.15 |
| Day’s High | ₹363.55 |
| Day’s Low | ₹318.05 |
| Volume | 11,308,382 |
| Value (Lacs) | ₹38,985.65 |
| VWAP | ₹352.96 |
| Beta (Volatility) | 0.96 |
| Market Capitalization | ₹3,857 Cr |
| 52-Week High | ₹571.00 |
| 52-Week Low | ₹257.90 |
| All-Time High | ₹571.00 |
| All-Time Low | ₹98.10 |
| Book Value Per Share | ₹119.92 |
| Dividend Yield | 1.51% |
| Face Value | ₹2 |
| 20D Avg Volume | 8,43,423 |
| 20D Avg Delivery (%) | 31.48 |
Founded in 1957 and headquartered in Thane, Maharashtra, Advanced Enzyme Technologies Ltd (AETL) is India’s largest and one of the world’s top enzyme manufacturing companies. It serves over 70 countries across healthcare, human nutrition, animal nutrition, textiles, leather, and paper industries.
Leading producer of eco-friendly enzyme-based solutions
Presence across pharmaceuticals, nutraceuticals, and food & beverages
Diversified revenue streams from domestic and global markets
Strong research & development base with over 600 proprietary enzyme formulations
Focus on innovation and sustainable industrial practices
| Investor Type | Holding (%) |
|---|---|
| Promoters | 43.08% |
| Retail & Others | 25.02% |
| Foreign Institutions | 23.46% |
| Mutual Funds | 5.46% |
| Other Domestic Institutions | 2.99% |
This diversified shareholding pattern shows both strong promoter confidence and significant foreign institutional interest.
| Year | Minimum Target (₹) | Maximum Target (₹) |
|---|---|---|
| 2025 | 350 | 380 |
| 2026 | 400 | 440 |
| 2027 | 460 | 500 |
| 2028 | 520 | 570 |
| 2029 | 580 | 640 |
| 2030 | 650 | 720 |
These projections are based on market performance, EPS growth, P/E ratios, global enzyme demand, and the company’s expansion strategies.
By 2025, the company is expected to remain stable with potential upside due to higher demand in pharma and nutraceuticals.
Why?
Increasing exports in enzyme-based medicines
Rising adoption of eco-friendly industrial enzymes
Strong institutional support
Investment Advice: Long-term investors can start accumulating shares at current levels.
In 2026, improved R&D outcomes and partnerships are likely to boost earnings.
Why?
Higher margins from healthcare segment
Rising global nutraceutical demand
Increased adoption in food processing industries
Investment Advice: Hold existing positions and consider SIPs for steady accumulation.
AETL may achieve stronger growth due to global expansion.
Why?
New product launches in nutrition and pharma
Strong demand from international markets
Favorable government policies for biotech sector
Investment Advice: Suitable for medium-term investors looking for steady compounding.
By 2028, Advanced Enzyme could break its previous high and move toward new records.
Why?
Expanding capacity utilization
Strong EPS and profitability outlook
Growth in animal nutrition & food industries
Investment Advice: Good time to reinvest dividends for wealth creation.
The company’s global leadership in sustainable enzymes may push valuations higher.
Why?
Innovation-driven growth
Enhanced exports to developed markets
Growing demand in pharmaceuticals and FMCG
Investment Advice: Continue to hold for long-term gains; ideal for investors with moderate risk appetite.
By 2030, Advanced Enzyme Technologies could become a leading global biotech brand.
Why?
Strong leadership and promoter trust
Rising global enzyme applications
Consistent growth in revenue and net profit
Investment Advice: A long-term wealth creation stock; ideal for retirement or 10+ year portfolios.
Yes. Advanced Enzyme Technologies Ltd is fundamentally strong, has growing global demand, and shows consistent promoter confidence.
Leadership in enzyme-based biotechnology
Wide product portfolio across multiple industries
Strong R&D and intellectual property base
Consistent dividend payout
Global economic slowdown affecting exports
Volatility due to dependency on pharma demand
Competition from international biotech firms
Advanced Enzyme Technologies Ltd is a promising biotech stock with long-term growth potential. Currently priced around ₹324, analysts expect it to reach ₹650–₹720 by 2030. With strong fundamentals, diverse revenue streams, and global expansion plans, this stock can be a cornerstone in long-term portfolios.
Investors should monitor quarterly results, global biotech trends, and domestic policies before making fresh entries.
1. What is the share price target for Advanced Enzyme Technologies in 2025?
The expected target for 2025 ranges between ₹350 – ₹380.
2. Is Advanced Enzyme Technologies a good buy now?
Yes, if you’re a long-term investor. The company is fundamentally strong with good growth prospects.
3. What is the future outlook of Advanced Enzyme Technologies?
The outlook is positive due to rising global demand for enzymes, nutraceuticals, and pharmaceuticals.
4. What is the 2030 target of Advanced Enzyme Technologies?
By 2030, the stock may trade between ₹650 – ₹720 depending on market conditions.
5. What is the current market capitalization of Advanced Enzyme Technologies?
As of August 2025, the market cap is around ₹3,857 Cr.
6. How much has Advanced Enzyme increased from its 52-week low?
It has risen from ₹257.90 (52-week low) to ₹363.55, showing strong recovery.
7. Should I hold Advanced Enzyme for the long term?
Yes, long-term investors can hold as it offers growth, dividends, and global exposure.
8. What is the promoter holding in Advanced Enzyme Technologies?
Promoters hold 43.08% of the company’s shares.
9. Does Advanced Enzyme Technologies give dividends?
Yes, it has a dividend yield of 1.51%.
10. How do I invest in Advanced Enzyme Technologies?
You can invest via NSE and BSE through a Demat and trading account.
Disclaimer: This article is for educational purposes only. Stock market investments are subject to risks. Please consult your financial advisor before investing.
Register & Login